Current state of the economics of palliative and end-of-life care: A clinical view
Eight years ago, a series of special articles on the economics of palliative and end-of-life care identified myriad challenges for the field, including a shortage of primary research, difficulties in methodology and measurement, and limited strategic approach to growing the evidence base. 1 The progress demonstrated by the strength and breadth of articles in this special edition of Palliative Medicine offers encouragement for clinicians, economists, policymakers and patients alike. Although still relatively small, the economics of palliative care is now a vibrant field in which rigorous original research, thoughtful methodological development and strategic thinking are all in evidence. This is important. The growth of this kind of work reflects the formal argument for economic evaluation: resources for the provision of healthcare interventions will always be scarce, decisions must be made in the allocation of scarce resources and palliative care must therefore demonstrate its value alongside other, often better established, areas of the system. Real-world competition for resources is growing stronger as demographic change increases the demand for services and fiscal austerity restricts their supply. Economic studies are essential if palliative care is to maintain the gains it has achieved over the last 25 years and continue to expand to address unmet needs. Additionally, economic analyses are critical in order to adequately develop, plan and deliver new models of palliative care delivery.
The greatest challenge facing health systems today is the growing population of older adults and the increasing prevalence of multimorbidity, functional impairment and dementia. These trends reflect the demographic transition towards older populations who are living longer, together with the epidemiological transition from predominantly infectious towards non-communicable diseases. As more people live longer with multiple serious illnesses and functional and cognitive impairment, the need for skilled, co-ordinated care that appropriately addresses complex needs is growing substantially. Inherent to that challenge is the heterogeneity of the population and a need to tailor care to different groups. Annicka et al. 2 provide data from the Netherlands illustrating that expenditures and settings vary according to specific chronic conditions, highlighting that care of people with serious illness must be adapted to meet the preferences and needs of those people and their family caregivers, and that particular consideration must be given to people with dementia. This idea that care of the seriously ill must be adaptive to disease profiles is given further credence by findings that total number of conditions drives expenditures 3 and that palliative care's effect on costs varies by number of conditions. 4 In this context, palliative care can be viewed as a complex response to a complex problem. A primary challenge for clinicians and economists to address in the coming years is to improve understanding of which interventions and settings are more or less effective and appropriate for people with different conditions and combinations of conditions.
An under-examined issue in economics of palliative care is the family caregiver perspective, addressed by articles from Rowland et al., 5 Dzingina et al. 6 and Brick et al. 7 While studies have looked in some detail at system costs, and in particular recorded a consistent pattern of cost-savings with respect to hospital costs, we know that hospital inpatients represent a minority of people with palliative care need and that formal utilisation of services does not fully reflect the cost of caring for someone with serious illness. Thus, the dataset compiled by Rowland and colleagues indicating that in England caregivers spend an average of 10 h/day, as well as substantial amounts of their own money, in end-of-life cancer care gives food for thought on how health systems and societies can provide care in an equitable and fair manner. In descriptive analysis of a population with refractory breathlessness in advanced chronic disease in England, Dzingina and colleagues report that informal caregivers account for over twice the costs of the formal system. With their data from Ireland, Brick and colleagues suggest that in the last year of life informal care costs make up around a quarter of total costs. The analyses by Brick and colleagues also highlight the potential for palliative care services in one setting to save costs in another, further emphasising the importance of the widest possible perspective in understanding palliative care's true economic impact.
This high reliance on informal caregivers has important policy implications given changing population demographics characterised by increasing numbers of older adults and decreasing numbers of persons in subsequent 695680P MJ0010.1177/0269216317695680Palliative MedicineEditorial editorial2017 Editorial generations (i.e. potential caregivers). In an age of multimorbidity, a growing proportion of illness burden will be carried by those living and cared for at home, thus putting an onus on clinicians and policymakers to think beyond traditional care settings. The contribution of May et al. 8 further illustrates the point. They report that lower hospital costs following palliative care consultation mainly accrue through shorter length of stay and not reduced high-intensity treatments as previously understood. These findings have implications for how hospital palliative care improves patient experience, suggesting that discharge planning may be as important as avoiding non-beneficial care, but also imply a risk that highprofile formal 'cost-savings' are shifted onto families following early discharge. It is vital that the formal and informal costs, not to mention the health-effects, for those caregivers do not remain invisible and are given greater consideration in policy discussions. Policy changes, such as introduction of compassionate care benefits 9 (paid to informal carers temporarily away from work to provide care to a gravely-ill family member) and expanded coverage of homecare services, will become increasingly important.
The most prominent methodological debate in economics of palliative care is the so-called 'QALY problem' around quality-adjusted life years. While some of the technical aspects of this conversation may discourage non-economists, and the measurement of patient experience in seriously-ill populations is never straightforward, the essential point is clear enough: fully measuring the value of a palliative care intervention requires evaluation not only of costs but also of outcomes, particularly in the context of interventions that extend survival. 10 The contribution of Wichmann et al. 11 in synthesising systematically the debate to date is therefore welcome. Continued efforts to capture both costs and outcomes are essential if palliative care is to enjoy a level playing field when under consideration from policymakers. Hopefully the predominantly conceptual work produced in this area to date will now be supplemented by a larger number of studies with empirical data. 12 A key strategic goal of a relatively small, relatively new field like palliative care is international collaboration. A review of funding models of palliative care across different countries by Groenveld et al. 13 represents an excellent example of genuinely international collaborative research. Standardised approaches to describing and understanding funding models are essential to underpin future international collaborative research, and the work of Groenveld and colleagues provides one of the first attempts at this for palliative care. However, this is not without its challenges; the authors signal a note of caution in concluding that cross-national comparisons are highly complex and require the funding and policy context in each country of interest to be taken into account.
The growing strength of economics research in palliative care demonstrated by this special edition lays a valuable foundation for the future. It is essential that economic research in our field continues to grow, and in particular that it addresses the challenges posed by a rapidly expanding older population. If palliative care is a complex response to a complex problem, then the evidence to underpin its provision must also be sophisticated, thoughtful and rigorous. Clinicians, researchers and policymakers alike must be flexible in responding to the many different facets of changing patterns of need and delivering appropriate healthcare responses built on this evidence.
